PDF(568 KB)
Clinical characteristics and outcomes of neonatal dengue fever in Foshan
Feng-Juan LUO, Yi-Heng DAI, Jun CHEN, Gui-Long YUAN, Wen-Hui MO, Qi-Qi XU, Wen-Qiu JIE, Wei-Zhong GUO, Zhi-Qing DENG, Long-Sheng LI, Ji-Peng SHI
Chinese Journal of Contemporary Pediatrics ›› 2026, Vol. 28 ›› Issue (7) : 812-817.
PDF(568 KB)
PDF(568 KB)
Clinical characteristics and outcomes of neonatal dengue fever in Foshan
Objective To study the clinical characteristics, treatment, and outcomes of neonatal dengue fever in Foshan. Methods A retrospective study was conducted on 49 neonatal dengue fever cases collected from eight hospitals in Foshan between June and November 2024. Clinical characteristics and outcomes were evaluated. Cases were divided into an early-onset group (diagnosed ≤7 days of age; n=32) and a late-onset group (diagnosed 7 days of age; n=17) for comparison of clinical characteristics. Results Among the 49 neonates, fever was the predominant symptom (45 cases, 92%), followed by bleeding tendency (12 cases, 24%), tachypnea (11 cases, 22%), and jaundice (5 cases, 10%). The mothers of 30 neonates (61%) had perinatal dengue infection. Rates of maternal peripartum fever, confirmed maternal dengue fever during pregnancy, and perinatal dengue infection were significantly higher in the early-onset group than in the late-onset group (P0.05). The early-onset group had a longer hospital stay than the late-onset group (P0.05). Alanine aminotransferase levels were significantly higher in the late-onset group than in the early-onset group (P0.05). Symptomatic treatments, including short-term hemostatic therapy, nasal cannula oxygen supplementation, and noninvasive positive pressure ventilation when indicated, resulted in favorable outcomes without severe cases or deaths. Conclusions Neonatal dengue fever in Foshan is associated with maternal perinatal dengue infection. Fever is the predominant clinical manifestation. Clinical characteristics differ by age at diagnosis, but overall prognosis is good. During dengue epidemic seasons, prevention and screening of perinatal dengue fever in pregnant women should be strengthened, and early laboratory tests such as pathogen detection and blood biochemistry should be performed on high-risk neonates.
Dengue fever / Clinical characteristic / Prognosis / Perinatal infection / Neonate
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
WHO. Dengue guidelines, for diagnosis, treatment, prevention and control[EB/OL]. (2009-04-21)[2025-07-27].
|
| [7] |
中华人民共和国国家卫生和计划生育委员会. 登革热诊疗指南(2014年第2版)[J]. 中药新药与临床药理, 2016, 27(1): 138-142. DOI: 10.3969/j.issn.1003-9783.2016.01.030 .
|
| [8] |
|
| [9] |
|
| [10] |
中华医学会感染病学分会, 中华医学会热带病与寄生虫学分会, 中华中医药学会急诊分会.中国登革热临床诊断和治疗指南[J]. 中华传染病杂志, 2018, 36(9): 513-520. DOI: 10.3760/cma.j.issn.1000-6680.2018.09.001 .
|
| [11] |
谭丽梅, 王俊平, 曾凡森, 等. 2014年广州市新生儿登革热12例临床特点分析并文献复习[J]. 中华儿科杂志, 2015, 53(12): 943-947. DOI: 10.3760/cma.j.issn.0578-1310.2015.12.015 .
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
CDC. Clinical testing guidance for dengue[EB/OL]. (2025-06-20)[2025-07-27].
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
WHO. Dengue[EB/OL]. [2025-07-27].
|
| [26] |
|
| [27] |
|
| [28] |
|
所有作者均声明无利益冲突。